Spatial Repellents for Malaria Control - Trial NCT06122142
Access comprehensive clinical trial information for NCT06122142 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Notre Dame and is currently Not yet recruiting. The study focuses on Malaria. Target enrollment is 2160 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Notre Dame
Timeline & Enrollment
N/A
Jan 01, 2024
Jan 01, 2025
Primary Outcome
Effectiveness of SR against malaria infection (both first-time and recurrent).
Summary
The primary objective of the study is to demonstrate and quantify the effectiveness of a
 spatial repellent (SR) product, in reducing malaria infection in humans under operational
 program conditions in a humanitarian assistance context. The design will be a cluster
 Randomized Control Trial (cRCT) representing an operational research study.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06122142
Device Trial